- Drug screening, offering analysis for the presence of illicit or prescription drugs in various biological samples, is an increasingly vital component of maintaining safety and compliance across diverse settings due to its ability to deter substance abuse and identify individuals requiring assistance.
- The escalating demand for drug screening is primarily fueled by stringent regulatory requirements in workplaces, the growing awareness of the impact of drug abuse on public health and safety, and technological advancements leading to more accurate and rapid testing methods.
- U.S. dominates the Drug Screening market with the largest revenue share of 58.27% in 2025, due to stringent workplace drug testing regulations, high healthcare expenditure, and the presence of numerous testing laboratories and service providers.
- Urine Tests segment is expected to dominate the Drug Screening market with a market share of 35.79% in 2025, driven by its cost-effectiveness, ease of collection, and established use in various screening programs.
